For: | Amador-Cañizares Y, Martínez-Donato G, Álvarez-Lajonchere L, Vasallo C, Dausá M, Aguilar-Noriega D, Valenzuela C, Raíces I, Dubuisson J, Wychowski C, Cinza-Estévez Z, Castellanos M, Núñez M, Armas A, González Y, Revé I, Guerra I, Pérez Aguiar &, Dueñas-Carrera S. HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin. World J Gastroenterol 2014; 20(1): 148-162 [PMID: 24415868 DOI: 10.3748/wjg.v20.i1.148] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i1/148.htm |
Number | Citing Articles |
1 |
Dorta Guridi Zaily, Castellanos Fernandez Marlen, Dueñas-Carrera Santiago, Martínez Donato Gillian, Valenzuela Silva Carmen, Cinza Estevez Zurina, Arús Soler Enrique R., Alvarez-Lajonchere Liz, González Fabián Lisset, Lazo del Vallín Sacha, Ferrer Bataille Elena. Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C. Current Therapeutic Research 2017; 85: 20 doi: 10.1016/j.curtheres.2017.04.006
|
2 |
Natalia Echeverría, Pilar Moreno, Juan Cristina. Human Virology in Latin America. 2017; : 333 doi: 10.1007/978-3-319-54567-7_17
|
3 |
Juris Jansons, Irina Sominskaya, Natalia Petrakova, Elizaveta S. Starodubova, Olga A. Smirnova, Ekaterina Alekseeva, Ruta Bruvere, Olesja Eliseeva, Dace Skrastina, Elena Kashuba, Marija Mihailova, Sergey N. Kochetkov, Alexander V. Ivanov, Maria G. Isaguliants. The Immunogenicity in Mice of HCV Core Delivered as DNA Is Modulated by Its Capacity to Induce Oxidative Stress and Oxidative Stress Response. Cells 2019; 8(3): 208 doi: 10.3390/cells8030208
|
4 |
Benoit Callendret, Heather B. Eccleston, William Satterfield, Stefania Capone, Antonella Folgori, Riccardo Cortese, Alfredo Nicosia, Christopher M. Walker. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct‐acting antiviral. Hepatology 2016; 63(5): 1442 doi: 10.1002/hep.28309
|
5 |
G. Martínez-Donato, B. Piniella, D. Aguilar, S. Olivera, A. Pérez, Y. Castañedo, L. Alvarez-Lajonchere, S. Dueñas-Carrera, J. W. Lee, N. Burr, M. Gonzalez-Miro, B. H. A. Rehm, D. L. Burns. Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System. Clinical and Vaccine Immunology 2016; 23(4): 370 doi: 10.1128/CVI.00687-15
|
6 |
Victoria Belousova, Ahmed A. Abd-Rabou, Shaker A. Mousa. Recent advances and future directions in the management of hepatitis C infections. Pharmacology & Therapeutics 2015; 145: 92 doi: 10.1016/j.pharmthera.2014.09.002
|
7 |
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Hepatitis C virus vaccine design: focus on the humoral immune response. Journal of Biomedical Science 2020; 27(1) doi: 10.1186/s12929-020-00669-4
|
8 |
Kimia Kardani, Parya Basimi, Mehrshad Fekri, Azam Bolhassani. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development. Expert Review of Clinical Pharmacology 2020; 13(9): 1001 doi: 10.1080/17512433.2020.1814743
|
9 |
Gina M Graziani, Jonathan B Angel. Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions. Journal of the International AIDS Society 2015; 18(1) doi: 10.7448/IAS.18.1.20497
|
10 |
Samaneh Karimkhanilouyi, Saeid Ghorbian. Nucleic acid vaccines for hepatitis B and C virus. Infection, Genetics and Evolution 2019; 75: 103968 doi: 10.1016/j.meegid.2019.103968
|
11 |
Navroop Nagra, Richard A. Kozarek, Blaire E. Burman. Therapeutic Advances in Viral Hepatitis A–E. Advances in Therapy 2022; 39(4): 1524 doi: 10.1007/s12325-022-02070-z
|